- Home
- BNTC vs ACTG Comparison
BNTC vs ACTG Comparison
Compare BNTC & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- ACTG
- Stock Information
- Founded
- BNTC 1995
- ACTG 1993
- Country
- BNTC United States
- ACTG United States
- Employees
- BNTC N/A
- ACTG N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- ACTG Multi-Sector Companies
- Sector
- BNTC Health Care
- ACTG Miscellaneous
- Exchange
- BNTC Nasdaq
- ACTG Nasdaq
- Market Cap
- BNTC 366.6M
- ACTG 363.5M
- IPO Year
- BNTC N/A
- ACTG 1996
- Fundamental
- Price
- BNTC $12.89
- ACTG $3.97
- Analyst Decision
- BNTC Strong Buy
- ACTG
- Analyst Count
- BNTC 6
- ACTG 0
- Target Price
- BNTC $23.83
- ACTG N/A
- AVG Volume (30 Days)
- BNTC 234.8K
- ACTG 167.8K
- Earning Date
- BNTC 05-14-2025
- ACTG 08-07-2025
- Dividend Yield
- BNTC N/A
- ACTG N/A
- EPS Growth
- BNTC N/A
- ACTG N/A
- EPS
- BNTC N/A
- ACTG N/A
- Revenue
- BNTC N/A
- ACTG $222,414,000.00
- Revenue This Year
- BNTC N/A
- ACTG $141.36
- Revenue Next Year
- BNTC N/A
- ACTG N/A
- P/E Ratio
- BNTC N/A
- ACTG N/A
- Revenue Growth
- BNTC N/A
- ACTG 65.22
- 52 Week Low
- BNTC $7.05
- ACTG $2.70
- 52 Week High
- BNTC $17.15
- ACTG $5.70
- Technical
- Relative Strength Index (RSI)
- BNTC 50.13
- ACTG 65.89
- Support Level
- BNTC $12.57
- ACTG $3.68
- Resistance Level
- BNTC $13.88
- ACTG $3.78
- Average True Range (ATR)
- BNTC 1.18
- ACTG 0.12
- MACD
- BNTC 0.02
- ACTG 0.02
- Stochastic Oscillator
- BNTC 62.63
- ACTG 90.00
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.